These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14990628)

  • 1. Tumor immunity in small-cell lung cancer.
    Darnell R
    J Clin Oncol; 2004 Mar; 22(5):762-4. PubMed ID: 14990628
    [No Abstract]   [Full Text] [Related]  

  • 2. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer.
    Monstad SE; Drivsholm L; Storstein A; Aarseth JH; Haugen M; Lang B; Vincent A; Vedeler CA
    J Clin Oncol; 2004 Mar; 22(5):795-800. PubMed ID: 14990634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.
    Whitson BA; D'Cunha J; Andrade RS; Kelly RF; Groth SS; Wu B; Miller JS; Kratzke RA; Maddaus MA
    Ann Thorac Surg; 2008 Dec; 86(6):1735-44. PubMed ID: 19021967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary.
    Pass H
    Ann Thorac Surg; 2008 Dec; 86(6):1744. PubMed ID: 19021968
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of PCNA expression in non-small cell lung cancer].
    Dworakowska D
    Pneumonol Alergol Pol; 2005; 73(3):292-6. PubMed ID: 16989169
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokines and chemokines as predictive markers in non-small cell lung cancer patients with brain metastases.
    Altundag O; Altundag K; Morandi P; Gunduz M
    Lung Cancer; 2005 Feb; 47(2):291-2. PubMed ID: 15639730
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines.
    Bazhin AV; Savchenko MS; Belousov EV; Jaques G; Philippov PP
    Lung Cancer; 2004 Sep; 45(3):299-305. PubMed ID: 15301870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
    Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
    BMC Cancer; 2004 Sep; 4():66. PubMed ID: 15367333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The yin-yang of tumor-associated neutrophils.
    Mantovani A
    Cancer Cell; 2009 Sep; 16(3):173-4. PubMed ID: 19732714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune microenvironments of lung and intraocular tumors.
    Sautès-Fridman C; Dieu-Nosjean MC; Damotte D; Fisson S; Fridman WH
    Bull Cancer; 2011 Jun; 98(6):58-61. PubMed ID: 21616749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic targets in non-small cell lung cancer: more is more.
    Gnjatic S
    Clin Cancer Res; 2005 Aug; 11(15):5331-2. PubMed ID: 16061843
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer.
    Pedretti M; Soltermann A; Arni S; Weder W; Neri D; Hillinger S
    Lung Cancer; 2009 Apr; 64(1):28-33. PubMed ID: 18799229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity.
    Nakamura Y; Noguchi Y; Satoh E; Uenaka A; Sato S; Kitazaki T; Kanda T; Soda H; Nakayama E; Kohno S
    Lung Cancer; 2009 Jul; 65(1):119-22. PubMed ID: 19193472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
    Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T; Takenoyama M; Ichiki Y; Mizukami M; So T; Hanagiri T; Sugio K; Yasumoto K
    Cancer; 2005 Jan; 103(1):200-8. PubMed ID: 15573370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
    Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
    Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response.
    Erlich R; Morrison C; Kim B; Gilbert MR; Alrajab S
    Cancer Invest; 2004; 22(2):257-61. PubMed ID: 15199608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer.
    Yu CJ; Shih JY; Lee YC; Shun CT; Yuan A; Yang PC
    Lung Cancer; 2005 Jan; 47(1):59-67. PubMed ID: 15603855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.